Back to search

Poland· PL-100440569

Gadoteric Acid Farmak

A gadotersäure product containing acidum gadotericum, registered in Poland by Farmak International Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC V08CA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedGadoteric Acid FarmakATCV08CA02REGISTER NO.PL-100440569PACKS LISTED12CHECKEDSeptember 27, 2026

Where it is registered

Gadotersäure is registered in 12 of 19 countries.

Countries holding a registration under ATC V08CA02 (gadotersäure), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Gadotersäure · ATC V08CA02

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Acidum gadotericum
Manufacturer
Farmak International Sp. z o.o.
Country
Poland (PL)
ATC code
V08CA02
ATC class
Gadotersäure
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 12

  • gtin
    05909991477981
  • gtin
    05909991477998
  • gtin
    05909991478001
  • gtin
    05909991478018
  • gtin
    05909991478025
  • gtin
    05909991478032
  • gtin
    05909991478049
  • gtin
    05909991478056
  • gtin
    05909991478063
  • gtin
    05909991478070
  • gtin
    05909991478087
  • gtin
    05909991478094

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

31 interactions on record for gadotersäure.

Graded by severity as the source publishes them — 31 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Gadotersäure · interactions on record

31 records

  • 31 moderate

Most severe, free to view

  • PindololC07AA03moderate
  • PropranololC07AA05moderate
  • TimololC07AA06moderate
  • SotalolC07AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gadotersäure in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gadotersäure products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Artirem, Clariscan
  • Belgium · Artirem, Clariscan
  • Bulgaria · Дотаграф, Кларискан
  • Cyprus · Clariscan, Cyclolux
  • Czechia · Clariscan, Cyclolux
  • Germany · Clariscan, Cyclolux
  • Denmark · Clariscan, Dotagraf
  • Estonia · Clariscan, Cyclolux
  • Spain · Ácido Gadotérico Farmak, Clariscan
  • Finland · Clariscan, Dotarem
  • France · Acide Gadoterique Guerbet, Artirem
  • United Kingdom (Northern Ireland) · Clariscan, Cyclolux
  • Greece · Clariscan, Cyclolux
  • Croatia · Clariscan, Cyclolux
  • Hungary · Clariscan, Cyclolux
  • Ireland · Clariscan, Cyclolux
  • Iceland · Clariscan, Dotagraf
  • Italy · Claricyclic, Dotagraf
  • Lithuania · Clariscan, Dotagraf
  • Luxembourg · Artirem, Clariscan
  • Latvia · Clariscan, Cyclolux
  • Malta · Clariscan, Dotagraf
  • Netherlands · Artirem, Clariscan
  • Norway · Clariscan, Dotarem
  • Portugal · Clariscan, Cyclolux
  • Romania · Clariscan, Cyclolux
  • Sweden · Clariscan, Dotagraf
  • Slovenia · Clariscan, Cyclolux
  • Slovakia · Clariscan, Cyclolux

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aac17d56-43f9-48ca-9e5c-f2b62658ec90
GET /v1/drugs/aac17d56-43f9-48ca-9e5c-f2b62658ec90?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "0,5 mmol/ml",
  "packaging": "05909991477981 ¦ Rpz ¦ 143977\n10 fiol. 10 ml\n05909991477998 ¦ Rpz ¦ 143978\n10 fiol. 100 ml\n05909991478001 ¦ Rpz ¦ 143979\n10 fiol. 60 ml\n05909991478018 ¦ Rpz ¦ 143980\n1 fiol. 60 ml\n05909991478025 ¦ Rpz ¦ 143981\n1 fiol. 20 ml\n05909991478032 ¦ Rpz ¦ 143982\n1 fiol. 5 ml\n05909991478049 ¦ Rpz ¦ 143983\n1 fiol. 15 ml\n05909991478056 ¦ Rpz ¦ 143984\n1 fiol. 100 ml\n05909991478063 ¦ Rpz ¦ 143985\n10 fiol. 15 ml\n05909991478070 ¦ Rpz ¦ 143986\n10 fiol. 20 ml\n05909991478087 ¦ Rpz ¦ 143987\n1 fiol. 10 ml\n05909991478094 ¦ Rpz ¦ 143988\n10 fiol. 5 ml",
  "substance": "Acidum gadotericum 279.32 mg",
  "common_name": "Acidum gadotericum",
  "pl_product_id": "100440569",
  "pozwolenie_nr": "26955",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about gadotersäure.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.